African Spider Flower

Cleome gynandra delivers phenolic acids (protocatechuic acid, p-coumaric acid), flavonoids (quercetin, kaempferol, gallic acid), and novel cleogynones that exert antioxidant, anti-inflammatory, and selective cytotoxic effects through free radical scavenging, nitric oxide synthase inhibition, and apoptosis induction. In vitro, cleogynones B and C achieved 89.34% and 87.76% inhibition of HCT116 colon cancer cells at 25 µg/mL, while its ethyl acetate fraction showed an IC50 of 8.75 µg/mL, though no human clinical trial data currently validate these effects.

Origin & History

Cleome gynandra is native to tropical and subtropical Africa and Asia, thriving in disturbed soils, roadsides, and agricultural margins across sub-Saharan Africa, South and Southeast Asia, and parts of the Caribbean. It grows as a fast-maturing annual herb in warm, semi-arid to humid environments at low to mid elevations, tolerating poor soils and drought conditions that limit other leafy vegetables. In southern Africa, including KwaZulu-Natal and the Eastern Cape, it is both foraged wild and cultivated in subsistence gardens by Zulu and Xhosa communities as a staple nutritional and medicinal crop.

Historical & Cultural Context

Cleome gynandra has been used as both a food and medicine for centuries across sub-Saharan Africa and South Asia, with documented traditional applications in Zulu and Xhosa healing systems of southern Africa for expelling intestinal worms (anthelmintic use) and managing febrile illness attributed to malaria. In East Africa, particularly Tanzania and Kenya, the plant is known as 'Saget' or 'Mgagani' and consumed as a primary leafy vegetable by low-income rural communities who rely on it for iron and vitamin supplementation during seasons of low dietary diversity. Indian Ayurvedic and folk medicine traditions also record its use for eye conditions, skin diseases, and rheumatic pain, illustrating its parallel ethnomedicinal evolution across continents. Its cultural significance is reinforced by its role as an affordable, self-seeding crop accessible to subsistence farmers, making it a food security plant with deeply embedded community knowledge around preparation — including salt-water blanching to reduce bitterness from glucosinolates.

Health Benefits

- **Antioxidant Protection**: Phenolics and flavonoids scavenge free radicals with 80.64% DPPH inhibition at 200 µg/mL and 47.69% at 50 µg/mL, potentially reducing oxidative stress-driven cellular damage.
- **Anti-Inflammatory Activity**: Quercetin, kaempferol, and gallic acid suppress nitric oxide production and pro-inflammatory cytokine release; extracts outperformed comparators at 0.5 mg/mL in nitric oxide inhibition assays.
- **Anticancer Potential**: Novel compounds cleogynone B and C inhibit HCT116 colon cancer and MDA-MB-468 breast cancer cell proliferation in vitro at 25 µg/mL, with breast cancer cell inhibition exceeding 75% at 0.125–1.00 mg/mL over 48 hours.
- **Nutritional Micronutrient Density**: Leaves contain calcium 2.7–10.4 times higher and β-carotene 21.9 times higher than Brassica oleracea per 100 g dry weight, supporting bone health, immune function, and vision in micronutrient-deficient populations.
- **Anthelmintic and Antimalarial Use**: Zulu and Xhosa traditional medicine employs leaf decoctions to treat intestinal parasites and malaria symptoms, with phytochemicals including alkaloids, saponins, and terpenoids hypothesized as active agents, though controlled efficacy data are absent.
- **Blood Sugar Regulation Support**: Ethnopharmacological surveys document antidiabetic applications across African and Asian communities, with phenolic compounds potentially modulating glucose metabolism via alpha-glucosidase inhibition, though mechanistic human data are lacking.
- **Immune and Vitamin C Support**: Ascorbic acid content is 3.2–4.7 times higher than reference vegetables per 100 g dry weight, providing substantial dietary vitamin C that supports collagen synthesis, immune defense, and iron absorption from co-consumed plant foods.

How It Works

The phenolic compounds quercetin, kaempferol, gallic acid, and caffeic acid donate hydrogen atoms or electrons to neutralize reactive oxygen species via DPPH and ORAC mechanisms, while also chelating transition metals that catalyze Fenton reactions. Anti-inflammatory activity is mediated through inhibition of inducible nitric oxide synthase (iNOS), reducing nitric oxide overproduction, and suppression of NF-κB-dependent pro-inflammatory cytokines such as TNF-α and IL-6. The novel sesquiterpene-class cleogynones B and C induce concentration-dependent cytotoxicity in cancer cell lines through membrane disruption, oxidative stress escalation, and likely caspase-mediated apoptosis, as evidenced by near-complete inhibition of HCT116 cells at 25 µg/mL. At flavonoid concentrations exceeding 4 mg/mL, pro-oxidant activity dominates, with membrane lipid peroxidation and mitochondrial dysfunction contributing to cytotoxicity, illustrating a biphasic dose-response characteristic of polyphenol-rich extracts.

Scientific Research

The current evidence base for Cleome gynandra is confined entirely to in vitro cell line studies and phytochemical characterization analyses; no peer-reviewed human clinical trials have been published, and no registered trials appear in accessible databases. In vitro studies demonstrate compelling anticancer activity — cleogynones B and C achieved 89.34% and 87.76% cytotoxicity against HCT116 colon cancer cells at 25 µg/mL, and an ethyl acetate fraction produced an IC50 of 8.75 µg/mL — but these results cannot be extrapolated to human efficacy due to fundamental pharmacokinetic barriers including bioavailability, metabolism, and tissue distribution. Antioxidant studies using DPPH assays are robust at the methodological level, with dose-response data across multiple extract concentrations (3.125–200 µg/mL), providing reliable phytochemical characterization even without translational validation. The overall evidence quality is preclinical; while the phytochemical data are internally consistent and replicated across research groups, the absence of animal pharmacokinetic models and human trials means therapeutic claims remain speculative.

Clinical Summary

No human clinical trials investigating Cleome gynandra for anthelmintic, antimalarial, anticancer, anti-inflammatory, or nutritional supplementation outcomes have been identified in the peer-reviewed literature. All quantified efficacy data derive from in vitro experiments using isolated cancer cell lines (HCT116, MDA-MB-468) or cell-free antioxidant assays, which do not constitute clinical evidence of efficacy or safety in humans. Nutritional observational data from sub-Saharan African dietary studies confirm the plant's role as a significant source of calcium, iron, zinc, β-carotene, and vitamin C in communities relying on indigenous vegetables, lending indirect support to its nutritional value. Confidence in therapeutic applications remains very low pending pharmacokinetic studies, animal efficacy models, and ultimately randomized controlled trials.

Nutritional Profile

Cleome gynandra leaves are exceptionally nutrient-dense relative to common cultivated vegetables. Phosphorus content is 3.3–5.5 times higher than Beta vulgaris or Brassica oleracea per 100 g dry weight. Calcium is 2.7–10.4 times higher than comparator vegetables, supporting its use in preventing rickets and osteoporosis in calcium-deficient diets. Iron and zinc concentrations are elevated, though bioavailability is moderated by co-occurring phytates and tannins that form insoluble complexes. β-Carotene (pro-vitamin A) is present at concentrations 21.9 times higher than Brassica oleracea, while ascorbic acid (vitamin C) is 3.2–4.7 times higher than reference vegetables. Total phenolics reach 15.15 mg GAE/g dry weight and flavonoids 5.65 mg CE/g dry weight; individual phenolic acids include p-coumaric acid (23.9 µg/g DW), caffeic acid (2.27 µg/g DW), protocatechuic acid (11-fold above comparators), and p-hydroxybenzoic acid (6-fold above comparators). Carotenoids include β-cryptoxanthin and violaxanthin. Bioavailability of fat-soluble carotenoids (β-carotene, β-cryptoxanthin) is enhanced when leaves are cooked with dietary fat, consistent with traditional preparation methods. Antinutritional factors including glucosinolates, oxalates, and tannins reduce mineral bioavailability and are partially mitigated by boiling and discarding cooking water.

Preparation & Dosage

- **Fresh Leaves (Traditional Dietary)**: Harvested young leaves consumed boiled or sautéed as a daily vegetable; no standardized therapeutic dose established — typical serving sizes reflect cultural culinary norms (50–150 g fresh weight per meal).
- **Leaf Decoction (Traditional Medicinal)**: Zulu and Xhosa preparations involve boiling dried or fresh leaves in water to make a tea or decoction for anthelmintic or antimalarial use; precise volumes and concentrations are undocumented in standardized literature.
- **Acetone/Ethanol Extract (Research Use Only)**: Used in preclinical studies at concentrations of 0.5–25 µg/mL in vitro; no human-equivalent dosing has been derived from these concentrations, and concentrated extracts are not available as commercial supplements.
- **Ethyl Acetate Fraction (Research Use Only)**: Showed IC50 of 8.75 µg/mL (anticancer) and 25.40 µg/mL (breast cancer); these figures represent cell culture concentrations, not oral doses, and cannot be directly converted to supplemental dosing recommendations.
- **Dried Leaf Powder (Emerging Traditional)**: Sometimes used in regional African herbal practice; no standardization percentage, no validated extract ratio, and no established daily intake limit exist for any therapeutic indication.
- **Timing**: As a food ingredient, consumed with meals; medicinal decoctions are typically administered twice daily in traditional practice, though this is undocumented in controlled studies.

Synergy & Pairings

Consuming Cleome gynandra leaves with dietary fats (e.g., groundnut oil as practiced in traditional East African cooking) substantially enhances the bioavailability of fat-soluble carotenoids including β-carotene and β-cryptoxanthin through micellarization in the intestinal lumen. Co-consumption with vitamin C-rich foods or endogenous ascorbic acid from the leaves themselves enhances non-heme iron absorption by reducing ferric iron to the more bioavailable ferrous form, a mechanism particularly relevant in the iron-deficiency-prone populations who rely on this plant. Combining Cleome gynandra phenolics with other flavonoid-rich plants such as moringa (Moringa oleifera) or baobab (Adansonia digitata) is practiced in some West African culinary traditions and may provide additive antioxidant and anti-inflammatory activity, though controlled synergy studies have not been conducted.

Safety & Interactions

At dietary food amounts, Cleome gynandra is considered safe based on centuries of traditional consumption across multiple cultures with no documented mass adverse events; however, no formal human safety trials or established tolerable upper intake levels exist. At high extract concentrations exceeding 4 mg/mL flavonoid equivalent, in vitro data demonstrate pro-oxidant cytotoxicity via membrane disruption and oxidative stress, suggesting that concentrated supplemental extracts could pose cellular safety risks not present at food-equivalent doses. No specific drug interactions have been formally identified; however, the high vitamin K precursor content and potent antioxidant phenolics theoretically warrant caution in individuals taking anticoagulants (e.g., warfarin), and saponin content may affect intestinal permeability and absorption of co-administered drugs. Pregnancy and lactation safety has not been evaluated in controlled studies — traditional use in southern African communities includes pregnant women consuming the leaves as a vegetable, but medicinal-dose extracts should be avoided during pregnancy until safety data are available; individuals with glucosinolate-sensitive thyroid conditions should exercise caution given the plant's membership in glucosinolate-producing families.